检索

期
标题
作者
卷 26, 编号 1 (2024)
Hereditary forms of breast malignant neoplasms: prognosis, screening and prevention. A review
Sultanbaev A., Kolyadina I., Gilyazova I., Nasretdinov A., Musin S., Sultanbaeva N., Menshikov K.
PDF
(Rus)
卷 24, 编号 2 (2022)
Prospects for the treatment of neurofibromatosis type 1: A review
Mustafin R.
PDF
(Rus)
卷 24, 编号 1 (2022)
Osimertinib and routine practice: the experience of the drug application in different clinical situations in case of metastatic non-small cell lung cancer with an EGFR mutation. Case report
Orlov S., Baldin P., Diuzeva N., Krechetova A., Mordovskiy A., Moskovchenko A., Musaeva N., Romanchuk O.
PDF
(Rus)
卷 23, 编号 1 (2021)
Role and place of PARP inhibitors in the modern treatment algorithm of BRCA-associated HER2-negative metastatic breast cancer. Results of the educational and discussion events based on the “OncoForum” platform
Board E.
PDF
(Rus)
卷 17, 编号 2 (2015)
Neurofibromatosis type 1 syndrome associated with gastrointestinal stromal tumor
Abukhaidar O., Filonenko D., Arkhiri P., Meshcheriakov A., Nered S., Stilidi I.
卷 22, 编号 3 (2020)
Molecular genetic portrait of non-small cell lung cancer in Tambov region: regional experience
Ognerubov N., Sychev V., Kozlova N., Chang V.
PDF
(Rus)
卷 16, 编号 1 (2014)
New aspects of the first-line chemotherapy in colorectal cancer
Artamonova E.
卷 20, 编号 3 (2018)
The evolution of views on the possibilities of drug therapy in overcoming acquired resistance not associated with Т790М mutation to anti-EGFR drugs in non-small cell lung cancer
Karabina E., Lubchenko L., Garunov A.
PDF
(Rus)
卷 15, 编号 4 (2013)
The ways of erlotinib resistance overcoming in treatment of patients with eGFr mutated nsClC
Orlov S.
卷 19, 编号 1 (2017)
The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor
Ryazhenov V.
PDF
(Rus)
卷 19, 编号 1 (2017)
The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer
Demidova I.
PDF
(Rus)
卷 18, 编号 4 (2016)
Molecular genetic features of the head and neck (upper aerodigestive tract) mucosal melanoma
Ignatova A.
卷 18, 编号 1 (2016)
BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia)
Khokhlova S., Gorbunova V., Lyubchenko L., Imyanitov E.
PDF
(Rus)
卷 23, 编号 1 (2021)
The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia
Sokolova T., Aleksakhina S., Yanus G., Sultanbaev A., Menshikov K., Lysenko A., Zukov R., Zyuzyukina A., Murunova Y., Rossokha E., Bakharev S., Basova E., Kasmynina T., Shumskaya I., Bakshun Y., Musaeva K., Khasanova A., Dmitriev V., Bolieva M., Gadzaova C., Petrenko O., Maksimov D., Vladimirov V., Goldberg V., Popova N., Kibisheva M., Khamgokov Z., Vasilyev A., Iyevleva A., Imyanitov E.
PDF
(Rus)
卷 17, 编号 3 (2015)
Hereditary ovarian cancer
Demidova I.
1 - 15 的 15 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##